Life Science

Più recente

281 a 290 di 497
  • Quantification of damages: giving claimants the benefit of the doubt Accesso limitato

    Articolo

    Ultima consultazione: 16 November 2011 / Inviato: 16 November 2011

    Claimant are not entitled to the benefit of the doubt in assessing damages simply because a defendant’s breach of contract has made quantification of damages uncertain.

  • China Life Sciences workshop Accesso limitato

    Seminario

    Inviato: 10 November 2011

    Slides from a workshop held in our Shanghai office on 10 November 2011 in which our China and international life sciences specialists guide you through the latest trends and legal challenges.

  • The Supreme Court sets a lower threshold for industrial applicability in Human Genome Sciences Inc v Eli Lilly and Company Accesso limitato

    Articolo

    Inviato: 03 November 2011

    In a dramatic and important decision the UK Supreme Court has overturned a decision of the Court of Appeal, by holding that Human Genome Science’s patent for Neutrokine-α has the requisite industrial applicability.

  • German reform of the Medicinal Products Market Act: first implications Accesso limitato

    Articolo

    Ultima consultazione: 25 October 2011 / Inviato: 25 October 2011

    The Reform of the Medicinal Products Market Act in Germany is having a significant impact on the industry`s commercial strategy.

  • The new French Healthcare bill: improving safety by increasing transparency Accesso limitato

    Articolo

    Ultima consultazione: 25 October 2011 / Inviato: 25 October 2011

    The French Ministry of Public Health and Social Care has presented a significant new bill which aims to reinforce safety measures relating to pharmaceuticals and healthcare products, largely through rendering interaction between the industry and its regulators more transparent.

  • Significant changes to the UK Takeover Code Accesso limitato

    Seminario

    Inviato: 06 October 2011

    Edward Baker and Mark Curtis discuss the recent major changes to the UK Takeover Code and the practical implications for financial institutions.

  • Who is a “public official” in Europe? Accesso limitato

    Articolo

    Ultima consultazione: 06 October 2011 / Inviato: 06 October 2011

    A look at the approach different jurisdictions are taking over who might constitute a “public official” in the sphere of corporate compliance

  • Dawn Raid Guide

    Guida Cross Border

    Ultima consultazione: 20 November 2014 / Inviato: 05 September 2011

    Knowing how to respond to a dawn raid in an informed and efficient manner is an essential part of an organisation's risk management policies. This manual provides detailed information on dawn raids across a range of jurisdictions.

  • Dawn Raid Guide - European Union

    Generale

    Ultima consultazione: 01 September 2015 / Inviato: 05 September 2011

    EU antitrust - administrative

  • Dawn Raid Guide - France

    Generale

    Ultima consultazione: 20 November 2014 / Inviato: 05 September 2011

    France antitrust - administrative

281 a 290 di 497